# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 12


Where—
(a) the manufacturing authorisation relates to the assembly of an investigational medicinal product or EAMS medicinal product;
(b) that investigational medicinal product or EAMS medicinal product is not manufactured by the holder of the authorisation; and
(c) particulars as to the name and address of the manufacturer of, or of the person who imports, that investigational medicinal product or EAMS medicinal product had been given by the holder of the authorisation to the licensing authority,
the holder of the authorisation shall forthwith notify the licensing authority in writing of any changes in such particulars.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/7/paragraph/12 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-7/paragraph-12
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.